secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2024-07-11T23:59:59+00:00
Accession:  0001140361-24-032885
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA pre-announces Q2 revenue $8.0M-$8.4M; XTRAC base down, TheraClear X up
-----------------------------------------------------------------------------

- Preliminary Q2 2024 total revenue range: $8.0M - $8.4M.
- Domestic XTRAC installed base fell from 907 (Q1) to 881 (Q2) per device realignment.
- TheraClear X installed base grew from 104 (Q1) to 117 (Q2).
- Cash, cash equivalents, and restricted cash totaled $6.8M at quarter end.
- Full Q2 2024 results expected to be reported on August 14, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036124032885/0001140361-24-032885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036124032885/ef20032281_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-032885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer